Targeting degradation of RNA by RNase H using DNA hairpins

Biochemistry

Volumn 42, Issue 37, 2003, Pages 10945-10954

  Li, Jing ^a   Bourdelat Parks, Brooke ^a   Boatright, Jeffrey H ^b   Wartell, Roger M ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; DEGRADATION; DNA SEQUENCES; RNA;

INTRAMOLECULAR DUPLEX;

BIOCHEMISTRY;

DNA; RIBONUCLEASE H; SINGLE STRANDED DNA;

3' UNTRANSLATED REGION; ARTICLE; DNA DEGRADATION; DNA RNA HYBRIDIZATION; ENZYME DEGRADATION; ENZYME STRUCTURE; MISMATCH REPAIR; MOLECULAR STABILITY; PRIORITY JOURNAL; RNA BINDING; RNA DEGRADATION; TEMPERATURE;

BASE SEQUENCE; BINDING SITES; DNA; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES; PLASMIDS; RIBONUCLEASE H, CALF THYMUS; RNA; TEMPERATURE; THERMODYNAMICS; TRANSCRIPTION, GENETIC; ULTRAVIOLET RAYS;

EID: 0141431054     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi034897z     Document Type: Article

References (49)

1. Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., and Freier, S.M. (1993) Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression, J. Biol. Chem. 268, 14514-22.
2. Boiziau, C., Tarrago-Litvak, L., Sinha, N. D., Moreau, S., Litvak, S., and Toulme, J. J. (1996) Antisense oligonucleotides inhibit in vitro cDNA synthesis by HIV-1 reverse transcriptase, Antisense Nucleic Acid Drug Dev. 6, 103-9.
3. ten Asbroek, A. L., van Groenigen, M., Nooij, M., and Baas, F. (2002) The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides, Eur. J. Biochem. 269, 583-92.
4. Dean, N. M. (2001) Functional genomics and target validation approaches using antisense oligonucleotide technology, Curr. Opin, Biotechnol. 12, 622-5.
5. Khare, M. D., and Sharland, M. (2001) Cytomegalovirus treatment options in immunocompromised patients, Expert Opin. Pharmacother. 2, 1247-57.
6. Witherell, G. W. (2001) ISIS-14803, Curr Opin. Investig. Drugs 2, 1523-1529.
7. Chi, K. N., Gleave, M. E., Klasa, R., Murray, N., Bryce, C., Lopes de Menezes, D. E., D'Aloisio, S., and Tolcher, A. W. (2001) A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide and mitoxantrone in patients with metastatic hormone-refractory prostate cancer, Clin. Cancer Res. 7, 3920-7.
8. Flaherty, K. T., Stevenson, J. P., and O'Dwyer, P. J. (2001) Antisense therapeutics: lessons from early clinical trials, Curr. Opin. Oncol. 13, 499-505.
9. Morse, M. A. (2001) Technology evaluation: ISIS-2503, Curr. Opin. Mol. Ther. 3, 589-94.
10. Morris, M. J., Tong, W. P., Cordon-Cardo, C., Drobnjak, M., Kelly, W. K., Slovin, S. F., Terry, K. L., Siedlecki, K., Swanson, P., Rafi, M., DiPaola, R. S., Rosen, N., and Scher, H. I. (2002) Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer, Clin. Cancer Res. 8, 679-83.
11. Kausch, I., Lingnau, A., Endl, E., Sellmann, K., Deinert, I., Ratliff, T. L., Jocham, D., Sczakiel, G., Gerdes, J., and Bohle, A. (2003) Antisense treatment against Ki-67 MRNA inhibits proliferation and tumor growth in vitro and in vivo, Int. J. Cancer 105, 710-6.
12. Luger, S. M., O'Brien, S. G., Ratajczak, J., Ratajczak, M. Z., Mick, R., Stadtmauer, E. A., Nowell, P. C., Goldman, J. M., and Gewirtz, A. M. (2002) Oligodeoxynucleotide mediated inhibition of c-myb gene expression in autografted bone marrow, Blood 99, 1150-8.
13. Hibi, T., Inoue, N., Ogata, H., and Naganuma, M. (2003) Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease, J. Gastroenterol. 38, 36-42.
14. Gilar, M., Belenky, A., Smisek, D. L., Bourque, A., and Cohen, A. S. (1997) Kinetics of phosphorothioate oligonucleotide metabolism in biological fluids, Nucleic Acid Res. 25, 3615-20.
15. Hudziak, R. M., Barofsky, E., Barofsky, D. F., Weller, D. L., Huang, S. B., and Weller, D. D. (1996) Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation, Antisense Nucleic Acid Drug Dev. 6, 267-72.
16. Summerton, J. (1999) Morpholino antisense oligomers: the case for an RNase H-independent structural type, Biochim. Biophys. Acta 1489, 141-58.
17. Crinelli, R., Bianchi, M., Gentilini, L., and Magnani, M. (2002) Design and characterization of decoy oligonucleotides containing locked nucleic acids, Nucleic Acids Res. 30, 2435-43.
18. Woolf, T. M., Melton, D. A., and Jennings, C. G. (1992) Specificity of antisense oligonucleotides in vivo, Proc. Natl. Acad. Sci. U.S.A. 89, 7305-9.
19. Zhou, W., and Agrawal, S. (1998) Mixed-backbone oligonucleotides as second-generation antisense agents with reduced phosphorothioate-related side effects, Bioorg. Med. Chem. Lett. 8, 3269-74.
20. Shen, L. X., Kandimalla, E. R., and Agrawal, S. (1998) Impact of mixed-backbone oligonucleotides on target binding affinity and target cleaving specificity and selectivity by Escherichia coli RNase H, Bioorg. Med. Chem. 6, 1695-705.
21. Agrawal, S. (1999) Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides, Biochim. Biophys. Acta 1489, 53-68.
22. Wang, H., Cai, Q., Zeng, X., Yu, D., Agrawal, S., and Zhang, R. (1999) Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIα subunit of protein kinase A after oral administration, Proc. Natl. Acad. Sci. U.S.A. 96, 13989-94.
23. Wang, H., Wang, S., Nan, L., Yu, D., Agrawal, S., and Zhang, R. (2002) Antisense anti-MDM2 mixed-backbone oligonucleotides enhance therapeutic efficacy of topoisomerase I inhibitor irinotecan in nude mice bearing human cancer xenografts: in vivo activity and mechanisms, Int. J. Oncol. 20, 745-752.
24. Lok, C. N., Viazovkina, E., Min, K. L., Nagy, E., Wilds, C. J., Damha, M. J., and Parniak, M. A. (2002) Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2′-deoxy-2′ -fluoro-D-arabinose and 2′-deoxyribose nucleotides, Biochemistry. 41, 3457-67.
25. Li, J., and Wartell, R. M. (1998) RNase H1 can catalyze RNA/DNA hybrid formation and cleavage with stable hairpin or duplex DNA oligomers, Biochemistry 37, 5154-61.
26. Agrawal, S., Temsamani, J., and Tang, J.-Y. (1991) Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice, Proc. Natl. Acad. Sci. U.S.A. 88, 7595-9.
27. Rebowski, G., Wojcik, M., Boczkowska, M., Gendaszewska, E., Soszynski, M., Bartosz, G., and Niewiarowski, W. (2001) Antisense hairpin loop oligonucleotides as inhibitors of expression of multidrug resistance-associated protein 1: their stability in fetal calf serum and human plasma, Acta Biochim. Pol. 48, 1061-76.
28. Lautenberger, J. A. (1991) A computer program to assist in the preparation of oligonucleotide solutions, BioTechniques 10, 778-80.
29. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: Laboratory Manual, 2nd ed., p E.5, Cold Spring Harbor Laboratory Press, Woodbury, New York.
30. Serra, M. J., and Turner, D. H. (1995) Predicting thermodynamic properties of RNA, Methods Enzymol. 259, 242-61.
31. SantaLucia, J., Jr., and Turner, D. H. (1997) Measuring the thermodynamics of RNA secondary structure formation, Biopolymers 44, 309-19.
32. Mathews, D. H., Sabina, J., Zuker, M., and Turner, D. H. (1999) Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure, J. Mol. Biol. 288, 911-40.
33. SantaLucia, J., Jr. (1998) A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics, Proc. Natl. Acad. Sci. U.S.A. 95, 1460-5.
34. Sugimoto, N., Nakano, S., Katoh, M., Matsumura, A., Nakamuta, H., Ohmichi, T., Yoneyama, M., and Sasaki, M. (1995) Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes, Biochemistry 34, 11211-6.
35. Wu, P., Nakano, S.-I., and Sugimoto, N. (2002) Temperature dependence of thermodynamic properties for DNA/DNA and RNA/DNA duplex formation, Eur. J. Biochem. 269, 2821-30.
36. Bommarito, S., Peyret, N., and SantaLucia, J., Jr. (2000) Thermodynamic parameters for DNA sequences with dangling ends, Nucleic Acids Res. 28, 1929-34.
37. Ohmichi, T., Nakano, S., Miyoshi, D., and Sugimoto, N. (2002) Long RNA dangling end has large energetic contribution to duplex stability, J. Am. Chem. Soc. 124, 10367-72.
38. Li, Y., and Agrawal, S. (1995) Oligonucleotides containing G. A pairs: effect of flanking sequences on structure and stability, Biochemistry 34, 10056-62.
39. Peyret, N., Seneviratne, P. A., Allawi, H. T., and SantaLucia, J., Jr (1999) Nearest-neighbor thermodynamics and NMR of DNA sequences with internal A·A, C·C, G·G, and T·T mismatches, Biochemistry 38, 3468-77.
40. Allawi, H. T., and SantaLucia, J., Jr. (1998) Thermodynamics of internal C·T mismatches in DNA, Nucleic Acids Res. 26, 2694-701.
41. Sugimoto, N., Nakano, M., and Nakano, S. (2000) Thermodynamics-structure relationship of single mismatches in RNA/DNA duplexes, Biochemistry 19, 11270-81.
42. Paner, T. M., Amaratunga, M., Doktycz, M. J., and Benight, A. S. (1990) Analysis of melting transitions of the DNA hairpins formed from the oligomer sequences d[GGATAC(X)4GTATCC], Biopolymers 29, 1715-34.
43. Hogrefe, H. H., Hogrefe, R. I., Walder, R. Y., and Walder, J. A. (1990) Kinetic analysis of Escherichia coli RNase H using DNA-RNA-DNA/DNA substrates, J Biol. Chem. 265, 5561-6.
44. Huertas, D., and Azorin, F. (1996) Structural polymorphism of homopurine DNA sequences. d(GGA)n and d(GGGA)n repeats form intramolecular hairpins stabilized by different base-pairing interactions, Biochemistry 35, 13125-35.
45. Lesnik, E. A., and Freier, S. M. (1995) Relative thermodynamic stability of DNA, RNA, and DNA:RNA hybrid duplexes: relationship with base composition and structure, Biochemistry 34, 10807-15.
46. Donis-Keller, H. (1979) Site-specific enzymatic cleavage of RNA, Nucleic Acids Res. 7, 179-92.
47. Wu, H., Lima, W. F., and Crooke, S. T. (1999) Properties of cloned and expressed human RNase H1, J. Biol. Chem. 274, 28270-8.
48. Stein, D., Foster, E., Huang, S. B., Weller, D., and Summerton, J. (1997) A specificity comparison of four antisense types: morpholino, 2′-O-methyl RNA, DNA, and phosphorothioate DNA, Antisense Nucleic Acid Drug Dev. 7, 151-7.
49. Larrouy, B., Boiziau, C., Sproat, B., and Toulme, J. J. (1995) RNase H is responsible for the nonspecific inhibition of in vitro translation by 2′-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers, Nucleic Acids Res. 23, 3434-40.